Steroid hormones, cognitive processes and ageing;Steroidi, processi cognitivi e invecchiamento

Recenti Progressi in Medicina

Volumn 92, Issue 5, 2001, Pages 362-372

  Müller, Eugenio E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Adrenal steroids; Alzheimer disease; Brain ageing; Estrogens; Hippocampus; Menopause

Indexed keywords

CORTICOSTEROID; ESTROGEN; SEX HORMONE;

ADULT; AGED; AGING; ANIMAL; CENTRAL NERVOUS SYSTEM; FEMALE; HUMAN; MALE; PHYSIOLOGY; REVIEW;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGING; ANIMALS; CENTRAL NERVOUS SYSTEM; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE;

EID: 0039145626     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Kelly DD, Dodd J. Anatomical organization of the nervous system. In: Kandel ER, Schwartz JH, Jessell M (eds). Principles of Neural Science. New York: Elsevier 1991; 277-82.
2. Partridge WM, Frank HJL. Mechanisms of peptide transport from blood to brain. In: Müller EE, Mac Leod RM (eds). Neuroendocrine Perspectives. Amsterdam: Elsevier 1983; 107-21.
3. Baulieu EE. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Rec Progr Horm Res 1996; 52: 1-32.
4. Seeman TE, Robbins RJ. Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev 1994; 15: 233-60.
5. Agnati LF, Zoli M. Fisiologia e patologia dell'invecchiamento cerebrale. Edizione fuori commezrcio riservata ai medici, 1993; 3-89.
6. Algeri S, Senin U (a cura di). Il cervello senile, Milano: Pythagora Press 1995.
7. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 1986; 7: 284-01.
8. Wilkinson CW, Peskind ER, Raskind MA. Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human aging. Neuroendocrinology 1997; 65: 79-90.
9. Reul JMHM, De Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985; 117: 2505-11.
10. Meaney MJ, Aitken DH, Viau V et al. Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid receptor binding in the rat. Neuroendocrinology 1989; 50: 597-604.
11. Sapolsky RM. A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J Neurosci 1985; 5: 1228-32.
12. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998; 19: 269-301.
13. Jacobson L, Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 1991; 12: 118-34.
14. De Leon MJ, Mc Rae T, Tsai JR et al. Abnormal cortisol response in Alzheimer disease linked, to hippocampal atrophy. Lancet 1988; 2: 391-2.
15. Wetzel DM, Bohn MC, Kazee AM et al. Glucocorticoid receptor mRNA in Alzheimer diseased hippocampus. Brain Res 1995; 679: 72-81.
16. Eikelenboom P, Zhan SS, Van Goul WA et al. Inflammatory mechanisms in Alzheimer disease. Trends Pharmacol Sci 1994; 15: 447-50.
17. Barton RN, Horan MA, Weijers WM et al. Cortisol production rate and the urinary excretion of 17-hydroxycorticosteroids, free cortisol, and 6β-hydroxycortisol in healthy elderly men and women. J Gerontol 1993; 48: M213-18.
18. Greenspan SL, Rowe JW, Maitland LA et al. The pituitary-adrenal glucocorticoid response is altered by gender and disease. J Gerontol 1993; 48: M72-M7.
19. Starkman MN, Schteingart DE. Neuropsychiatric manifestations of patients with Cushing's syndrome. Arch Int Med 1981; 141: 215-9.
20. Perry EK, Tomlinson BE, Blessed G et al. Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. J Neurol Sci 1981; 51: 279-87.
21. Müller EE, Nisticò G. Brain messengers and the pituitary. San Diego: Academic Press 1989.
22. Perkins DO, Stern RA, Golden RN et al. Use of neuroendocrine tests in the psychiatric assessment of the medically ill patient. In McCubbin JA, Kaufmann PG, Nemeroff CB (eds). Stress, neuropeptides and systemic disease. San Diego: Academic Press 1991; 199-217.
23. McEwen BS, Alves SE, Bulloch K et al. Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997; 48: 8S-15S.
24. Kuiper GGJM, Van den Bernd G-JCM, van Lewin JPTM. Estrogen receptor and the SERM concept. J Endocrinol Invest 1999; 22: 594-603.
25. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999; 20: 279-307.
26. Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985; 89: 484-90.
27. Gibbs RB. Expression of estrogen receptor-like immunoreactivity by different subgroups of basal forebrain cholinergic neurons in gonadectomized male and female rats. Brain Res 1996; 720: 61-8.
28. Klaiber EL, Broverman DM, Vogel W et al. Estrogen replacement therapy for severe persistent depressions in women Arch Gen Psychiatry 1979; 36: 550-4.
29. Holst J, Backstrom T, Hammerbach S et al. Progesterone addiction during estrogen replacement therapy. Effects on vasomotor symptoms and mood. Maturitas 1989; 11: 13-9.
30. Sherwin BB, Tulandi T. «Add-back» estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 1996; 81: 2545-9.
31. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Pychiatr Scand 1987; 76: 465-79.
32. Birge SJ. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? Am Geriatr Soc 1996; 44: 865-70.
33. Tang M-X, Jacobs D, Stern Y et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348: 429-32.
34. Mulnard RA, Cotman GW, Einstein G et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. JAMA 2000; 283: 1007-15.
35. Yaffe K, Sawaya G, Lieberburg I. Estrogen therapy in post-menopausal women. Effects on cognitive function and dementia. JAMA 1998; 279: 688-95.
36. Shawitz BA, Shawitz SE. Estrogen and Alzheimer disease. Plausible theory, negative clinical trial. JAMA 2000; 283: 1055-6.
37. Yaffe K, Liu L-Y, Grady D et al. Cognitive decline in women in relation to non-protein bound oestradiol concentrations. Lancet 2000; 356: 708-12.